BSE NSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Laurus Labs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
540222
ISIN Demat
INE947Q01028
Book Value (Rs)
78.057879
NSE Symbol
LAURUSLABS
Divident Yield %
0.09
Market Cap
(Rs In Cr.)
23,863
P/E (TTM)
106.69
EPS (TTM)
4.15
Face Value
(Rs)
2
Back
Laurus Labs consolidated net profit declines 26.58% in the March 2024 quarter
25-Apr-24   Hrs IST

Net profit of Laurus Labs declined 26.58% to Rs 75.61 crore in the quarter ended March 2024 as against Rs 102.98 crore during the previous quarter ended March 2023. Sales rose 4.26% to Rs 1439.67 crore in the quarter ended March 2024 as against Rs 1380.90 crore during the previous quarter ended March 2023.

For the full year,net profit declined 79.68% to Rs 160.55 crore in the year ended March 2024 as against Rs 790.11 crore during the previous year ended March 2023. Sales declined 16.55% to Rs 5040.83 crore in the year ended March 2024 as against Rs 6040.55 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales1439.671380.90 4 5040.836040.55 -17
OPM %16.7720.68 -15.4226.36 -
PBDT209.52234.15 -11 620.941433.02 -57
PBT107.27147.14 -27 236.361108.94 -79
NP75.61102.98 -27 160.55790.11 -80

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)